🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07344636
Recruiting Not applicable

Effects of NR Supplementation on Metabolic Flexibility in Zone 2 Training

NCT07344636 · tracked via the Priya Life Science China tracker
Sponsor
ZHANG Jiaqi
Phase
Not applicable
Started
2026-01-06
Last updated
2026-03-18

Condition(s) studied

Health Adult Subjects

Investigational drug(s) / intervention(s)

Nicotinamide Riboside (NR)Nicotinamide Riboside (NR)

Nicotinamide Riboside (NR): 600 mg NR

Nicotinamide Riboside (NR): 300 mg NR

Study summary

Zone 2 training, a low-intensity endurance exercise performed at approximately 66-80% of VO₂max or near the first ventilatory threshold, has gained popularity for improving aerobic capacity, fat metabolism, and mitochondrial efficiency. It preserves glycogen stores and delays fatigue, making it an essential training method for both athletes and recreational exercisers. Nicotinamide adenine dinucleotide (NAD) is a vital metabolite that regulates cellular energy metabolism and redox homeostasis. It participates in oxidative reactions within the tricarboxylic acid cycle and electron transport chain, sustaining ATP synthesis and mitochondrial efficiency. Exercise influences multiple pathways of NAD metabolism, altering the NAD⁺/NADH ratio and thereby affecting energy production and fatigue resistance. Studies have shown that both aerobic exercise and NAD precursor supplementation (e.g., nicotinamide riboside \[NR\]) can elevate body NAD levels and enhance mitochondrial function, though findings remain inconsistent due to variations in dosage and participants' characteristics. This study aims to investigate how acute NR supplementation interacts with Zone 2 cycling training in adults. Specifically, it examines the temporal and dose-dependent effects of NR supplementation on metabolic flexibility and exercise performance. The results may clarify the potential synergistic benefits of combining NAD supplementation with low-intensity endurance training to improve aerobic adaptability.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Over 18 years old * BMI \<30 kg/m2 Exclusion Criteria: * Present of health conditions that contraindicate participation in exercise training, such as a history of cardiovascular disease, cancer, or musculoskeletal disorders * Currently taking vitamin B supplements and/or NAD precursors * Taking medication that may affect the test results

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
G02, Kwok Sports Building, The Chinese University of Hong Kong Hong Kong Please Select Recruiting

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07344636 on ClinicalTrials.gov ↗ ← All trials in China